Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections

Kaye, Keith S ; Boucher, Helen W ; Brown, Michelle L ; Aggrey, Angela ; Khan, Ireen ; Joeng, Hee-Koung ; Tipping, Robert W ; Du, Jiejun ; Young, Katherine ; Butterton, Joan R ; Paschke, Amanda

Antimicrobial agents and chemotherapy, 2020-04, Vol.64 (5) [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível